Search

Your search keyword '"Jevtovic, D"' showing total 170 results

Search Constraints

Start Over You searched for: Author "Jevtovic, D" Remove constraint Author: "Jevtovic, D"
170 results on '"Jevtovic, D"'

Search Results

1. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration

2. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

3. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study

4. Incidence of cancer and overall risk of mortality in individuals treated with raltegravir‐based and non‐raltegravir‐based combination antiretroviral therapy regimens

5. The extent of B‐cell activation and dysfunction preceding lymphoma development in HIV‐positive people†

6. Gender differences in the use of cardiovascular interventions in HIV‐positive persons; the D:A:D Study

7. Where are we with pre-exposure prophylaxis use in Central and Eastern Europe? Data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group

9. Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA

10. Long‐term effectiveness of recommended boosted protease inhibitor‐based antiretroviral therapy in Europe

12. Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy

13. Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens

17. Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA

21. Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohort

22. Liver-related death among HIV/hepatitis C virus-co-infected individuals

23. Where are we with pre‐exposure prophylaxis use in Central and Eastern Europe? Data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group.

25. Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression : A prospective cohort study

26. Infection-related and -unrelated malignancies, HIV and the aging population

27. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study

28. Tuberculosis among HIV-positive patients across Europe: changes over time and risk factors

30. Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study

31. Hyaluronic acid levels predict risk of hepatic encephalopathy and liver-related death in HIV/viral hepatitis coinfected patients

32. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study

33. Primary resistance to integrase strand-transfer inhibitors in Europe

34. Primary resistance to integrase strand-transfer inhibitors in Europe

35. Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA study

36. Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe

37. Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy : not all AIDS-defining conditions are created equal

38. Development of a definition for rapid progression (RP) of renal function in HIV-positive persons:the D:A:D study

39. Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations

40. Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe

41. Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe

42. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

43. Limited cross-border infections in patients newly diagnosed with HIV in Europe

44. Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients

45. Hepatitis c virus viremia increases the Incidence of chronic kidney disease in HIV-infected Patients

46. Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study

47. Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy

48. A standardized algorithm for determining the underlying cause of death in HIV infection as AIDS or non-AIDS related: results from the EuroSIDA study

49. A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA study

50. History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change

Catalog

Books, media, physical & digital resources